Stockreport

Revance Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Net loss: US$324.0m (loss narrowed by 9.1% from FY 2022). US$3.83 loss per share (improved from US$4.90 loss in FY 2022). All figures shown in the chart above are f [Read more]